Gilead Sciences, Inc.
Metabolites of bictegravir
Last updated:
Abstract:
The present invention provides metabolites of the antiviral drug bictegravir, including compositions and salts thereof, which are useful in the prevention and/or treatment of HIV as well as analytical methods related to the administration of bictegravir.
Status:
Grant
Type:
Utility
Filling date:
18 Jan 2019
Issue date:
22 Feb 2022